Autres langues Inter Pharma

Actions

IP

TH9474010005

Produits pharmaceutiques

Cours en clôture Thailand S.E. 02/10/2026			Varia. 5j.	Varia. 1 janv.
4,920 ^THB	+0,41%		-1,20%	+6,96%

14/08	Inter Pharma Public Company Limited publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
11/05	Inter Pharma Public Company Limited publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

14/08	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
11/05	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026
02/03	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025
02/03	Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026
12/11	Inter Pharma Public Company Limited (SET:IP) agreed to acquire an additional 49% stake in Interpharma- ZEAvita Company Limited from Thai Union Ingredients.
11/11	Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
14/08/25	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
13/05/25	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025
16/04/25	Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal
16/04/25	Zhaoke Ophthalmology Limited Enters into Three Distribution and Supply Agreements with Interpharma Public Company Limited
01/04/25	Inter Pharma Public Company Limited Signs Exclusive Distribution Agreement with Zhaoke Ophthalmology Company Limited for Comprehensive Eye Care Innovation
25/02/25	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024
25/02/25	Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024
14/11/24	Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
11/09/24	Inter Pharma Public Company Limited (SET:IP) acquired 60% stake in Metta Medtech Company Limited from YNSET Company Limited, Sittisak Phanitpotchaman, Mayuree Phanitpotchaman and Suchada Srithong for THB 110 million
11/09/24	Inter Pharma Public Company Limited (SET:IP) acquired 60% stake in Metta Medtech Company Limited from YNSET Company Limited, Sittisak Phanitpotchaman, Mayuree Phanitpotchaman and Suchada Srithong for THB 110 million
14/08/24	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
14/05/24	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
26/04/24	Inter Pharma Public Company Limited Approves Dividend for the Year 2023, Payable on May 24, 2024
05/03/24	Inter Pharma Public Company Limited (SET:IP) agreed to acquire 60% stake in Metta Medtech Company Limited from Sittisak Phanitpotchaman for THB 110 million.
01/03/24	Inter Pharma Public Company Limited Proposes Dividend for the Year 2023, Payable on May 24, 2024
01/03/24	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
14/11/23	Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11/08/23	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
26/06/23	Inter Pharma Public Company Limited Announces Resignation of Mrs. Nattarin Polpuech as Director, Member of Risk Management Committee and Member of the Executive Committee